HS-130

N/A

Report date: 2024/02/21 12:08:07

Base Information

Drug NameHS-130
Drug Alias NameComPACTHS-130
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy
Mechanisms of ActionTumor necrosis factor ligand superfamily member 4 stimulants
TargetsTumor necrosis factor ligand superfamily member 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHeat Biologics
China Registration ClassN/A

Develop Information

Active CompaniesHeat Biologics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A